BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 25417855)

  • 1. Worsening pneumonitis due to a pharmacokinetic drug-drug interaction between everolimus and voriconazole in a renal transplant patient.
    Lecefel C; Eloy P; Chauvin B; Wyplosz B; Amilien V; Massias L; Taburet AM; Francois H; Furlan V
    J Clin Pharm Ther; 2015 Feb; 40(1):119-20. PubMed ID: 25417855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic interaction between everolimus and antifungal triazoles in a liver transplant patient.
    Pea F; Baccarani U; Tavio M; Cojutti P; Adani GL; Londero A; Baraldo M; Franceschi L; Furlanut M; Viale P
    Ann Pharmacother; 2008 Nov; 42(11):1711-6. PubMed ID: 18812562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of metabolic cytochrome P450 3A4 drug-drug interaction between everolimus and azole antifungals in a renal transplant patient.
    Billaud EM; Antoine C; Berge M; Abboud I; Lefeuvre S; Benammar M; Glotz D
    Clin Drug Investig; 2009; 29(7):481-486. PubMed ID: 19499965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Everolimus and Voriconazole Interaction in Lung Transplant Patients.
    Outeda Macías M; Salvador Garrido P; Elberdín Pazos L; Martín Herranz MI
    Ther Drug Monit; 2016 Jun; 38(3):305-12. PubMed ID: 26926669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of voriconazole and CYP2C19 polymorphisms for optimizing dosing regimens in renal transplant recipients.
    Lin XB; Li ZW; Yan M; Zhang BK; Liang W; Wang F; Xu P; Xiang DX; Xie XB; Yu SJ; Lan GB; Peng FH
    Br J Clin Pharmacol; 2018 Jul; 84(7):1587-1597. PubMed ID: 29607533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.
    Marty FM; Lowry CM; Cutler CS; Campbell BJ; Fiumara K; Baden LR; Antin JH
    Biol Blood Marrow Transplant; 2006 May; 12(5):552-9. PubMed ID: 16635790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
    Berge M; Guillemain R; Boussaud V; Pham MH; Chevalier P; Batisse A; Amrein C; Dannaoui E; Loriot MA; Lillo-Le Louet A; Billaud EM
    Transpl Infect Dis; 2009 Jun; 11(3):211-9. PubMed ID: 19302272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine.
    Kovarik JM; Kahan BD; Kaplan B; Lorber M; Winkler M; Rouilly M; Gerbeau C; Cambon N; Boger R; Rordorf C;
    Clin Pharmacol Ther; 2001 Jan; 69(1):48-56. PubMed ID: 11180038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of voriconazole on tacrolimus metabolism in a kidney transplant recipient.
    Capone D; Tarantino G; Gentile A; Sabbatini M; Polichetti G; Santangelo M; Nappi R; Ciotola A; D'Alessandro V; Renda A; Basile V; Federico S
    J Clin Pharm Ther; 2010 Feb; 35(1):121-4. PubMed ID: 20175821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirolimus and everolimus induced pneumonitis in adult renal allograft recipients: experience in a center.
    Rodríguez-Moreno A; Ridao N; García-Ledesma P; Calvo N; Pérez-Flores I; Marques M; Barrientos A; Sánchez-Fructuoso AI
    Transplant Proc; 2009; 41(6):2163-5. PubMed ID: 19715862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late Pulmonary Toxicity Associated With Everolimus in a Renal Transplant Patient and Review of the Literature.
    Velioglu A; Eryuksel E; Cimsit C; Tuglular S; Ozener C
    Exp Clin Transplant; 2018 Aug; 16(4):491-494. PubMed ID: 27001620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability and steady-state pharmacokinetics of everolimus in maintenance renal transplant patients.
    Budde K; Neumayer HH; Lehne G; Winkler M; Hauser IA; Lison A; Fritsche L; Soulillou JP; Fauchald P; Dantal J;
    Nephrol Dial Transplant; 2004 Oct; 19(10):2606-14. PubMed ID: 15316094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe everolimus-associated pneumonitis in a renal transplant recipient.
    Alexandru S; Ortiz A; Baldovi S; Milicua JM; Ruíz-Escribano E; Egido J; Plaza JJ
    Nephrol Dial Transplant; 2008 Oct; 23(10):3353-5. PubMed ID: 18658177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial.
    Budde K; Becker T; Arns W; Sommerer C; Reinke P; Eisenberger U; Kramer S; Fischer W; Gschaidmeier H; Pietruck F;
    Lancet; 2011 Mar; 377(9768):837-47. PubMed ID: 21334736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial.
    Pascual J; del Castillo D; Cabello M; Pallardó L; Grinyó JM; Fernández AM; Brunet M
    Transplantation; 2010 Apr; 89(8):994-1000. PubMed ID: 20335831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirolimus-itraconazole interaction in a hematopoietic stem cell transplant recipient.
    Said A; Garnick JJ; Dieterle N; Peres E; Abidi MH; Ibrahim RB
    Pharmacotherapy; 2006 Feb; 26(2):289-95. PubMed ID: 16466336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolution of sirolimus-induced pneumonitis after conversion to everolimus.
    Rehm B; Keller F; Mayer J; Stracke S
    Transplant Proc; 2006 Apr; 38(3):711-3. PubMed ID: 16647451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of voriconazole and sirolimus coadministration after allogeneic hematopoietic SCT.
    Ceberio I; Dai K; Devlin SM; Barker JN; Castro-Malaspina H; Goldberg JD; Giralt S; Adel NG; Perales MA
    Bone Marrow Transplant; 2015 Mar; 50(3):438-43. PubMed ID: 25599164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Adverse Events and Determinants of the Voriconazole Trough Concentration in Kidney Transplantation Recipients.
    Zhao YC; Lin XB; Zhang BK; Xiao YW; Xu P; Wang F; Xiang DX; Xie XB; Peng FH; Yan M
    Clin Transl Sci; 2021 Mar; 14(2):702-711. PubMed ID: 33202102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of pneumonitis in patients with advanced non-small cell lung cancer treated with everolimus (RAD001).
    White DA; Schwartz LH; Dimitrijevic S; Scala LD; Hayes W; Gross SH
    J Thorac Oncol; 2009 Nov; 4(11):1357-63. PubMed ID: 19745764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.